University of California San Francisco
Give to UCSFUCSF Children’s Hospital ranks among the nation’s best children’s hospitals in eight specialties and is one of the top-ranked facilities in California, according to the new 2010-11 “America’s Best Children’s Hospitals” survey conducted by <i>U.S. News & World Report</i>.
The UCSF community is invited to a symposium to address unsolved health problems, such as cancer and malaria, as a tribute to the 11-year tenure of Mike Bishop, MD, former chancellor of UCSF.
The UCSF Helen Diller Family Comprehensive Cancer Center hosted an afternoon event on the Mission Bay campus on May 12 to showcase recent progress and current research directions in the fight against cancer.
The cancer vaccine sipuleucel-T -- now commercially branded as Provenge -- will soon be available at a select group of medical centers nationwide, including UCSF.
Targeted therapies tailored to the unique biology of brain tumors may offer renewed hope to children diagnosed with the number one cause of cancer death, according to faculty at UCSF Children’s Hospital.
For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) – the most common form of non-invasive breast cancer – are at risk of developing more invasive tumors in later years.
Kevin Barrows, MD, has been appointed as director of Clinical Programs for the UCSF Osher Center for Integrative Medicine.
UCSF plans to begin construction of the new 289-bed children’s, women’s and cancer hospital complex at Mission Bay this year, says CEO Mark Laret.
UCSF has appointed Jeffrey A. Bluestone, PhD, a preeminent scientist and proven campus leader, as UCSF executive vice chancellor and provost.
Taking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.
Mitch Berger, chair of the Department of Neurological Surgery at UCSF, has been named to the NFL’s newly renamed committee on head, neck and spine medical committee.
UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.
UCSF scientists have discovered how a mutated gene known as Kras is able to hijack mouse cells damaged by acute pancreatitis, putting them on the path to becoming pancreatic cancer cells.
New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.
A panel of experts appointed by Mayor Gavin Newsom recently presented an action plan as the approaching “age wave may bring a potential crisis in Alzheimer’s and dementia care” to San Francisco.
UCSF researchers have identified a molecular mechanism that explains why patients with tumors of the thymus, or thymoma, often develop autoimmune disorders.
A new discovery about cancer and the immune system points to previously unrecognized targets for drug development to battle solid tumors.
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.
Walter S. Newman, a leading San Francisco businessman, philanthropist, and community leader, has joined the Board of Directors of NCIRE-The Veterans Health Research Institute.
Senator Arlen Specter will join UCSF Chancellor Sue Desmond-Hellmann for a town hall meeting to talk about health care reform, federal funding of scientific research and other important issues on February 16.
UCSF Chancellor Susan Desmond-Hellmann outlines a vision for faster development of better, cheaper drugs to fight cancer.
A UCSF analysis of published studies on the relationship between Alzheimer’s disease and smoking indicates that smoking cigarettes is a significant risk factor for the disease.
UCSF experienced the highs and the lows of 2009, a year that marked the beginning of a leadership shift at the health sciences University.
Cancer survivor David Servan-Schreiber, a physician, neuroscientist and science writer, will speak about preventing and treating cancer at UCSF on Friday, Jan. 15.